10 Best All-Time High Stocks to Buy According to Analysts

Page 9 of 9

1. Merus N.V. (NASDAQ:MRUS

Price: $65.92

All-Time High: $67.25

Number of Hedge Fund Holders: 53

Analyst Upside Potential: 37.29%

Merus N.V. (NASDAQ:MRUS) is one of the Best All-Time High Stocks to Buy According to Analysts. On June 10, Tazeen Ahmad from Bank of America Securities maintained a Buy rating on Merus N.V. (NASDAQ:MRUS), with a $92 price target.

The analyst noted that a key trial is the ongoing Phase 2 study of Petosemtamab for metastatic colorectal cancer. This trial focuses on different groups of patients with specific genetic types who have not had EGFR treatment before. Ahmad noted that this step-by-step approach would enable the company to better identify responsive patients and is crucial due to the sizable market potential of metastatic colorectal cancer.

Moreover, the treatment works by targeting two molecules, EGFR and LGR5, which allows the drug to fight cancer stem cells. In addition to this, the company is also moving forward with a Phase 3 trial for Petosemtamab in head and neck squamous cell carcinoma. The analyst noted that the interim results suggest that the treatment has the potential to become first in line.

Merus N.V. (NASDAQ:MRUS) is a biotechnology company based in the Netherlands. The company focuses on creating advanced cancer treatments using its unique Multiclonics technology.

While we acknowledge the potential of MRUS to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than MRUS and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 9 of 9